84 related articles for article (PubMed ID: 32550718)
1. FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials.
Kaddu-Mulindwa D; Altmann B; Held G; Angel S; Stilgenbauer S; Thurner L; Bewarder M; Schwier M; Pfreundschuh M; Löffler M; Menhart K; Grosse J; Ziepert M; Herrmann K; Dührsen U; Hüttmann A; Barbato F; Poeschel V; Hellwig D
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3550-3559. PubMed ID: 33928400
[TBL] [Abstract][Full Text] [Related]
2. Patients undergoing multiple
Indrakanti S; Li X; Rehani MM
Br J Radiol; 2022 Jul; 95(1135):20211225. PubMed ID: 35348374
[TBL] [Abstract][Full Text] [Related]
3. Distinct FDG PET/CT avidity among newly diagnosed intravascular large B-cell lymphoma patients: a descriptive observational study.
Zhao D; Zhang Y; Zhu W; Huo L; Zhou D; Wang W; Wei C; Zhang W
Ann Hematol; 2024 Feb; 103(2):545-552. PubMed ID: 37932469
[TBL] [Abstract][Full Text] [Related]
4. Extranodal NK/T-cell lymphoma with localized relapse in bone marrow of lower leg detected using PET-CT.
Nakamura T; Tatetsu H; Higuchi Y; Endo S; Shiraishi S; Kawanaka K; Imakane D; Sonoda M; Furuta R; Shichijo T; Honda Y; Karube K; Mikami Y; Nosaka K; Matsuoka M; Yasunaga JI
J Clin Exp Hematop; 2024; 64(1):45-51. PubMed ID: 38538318
[TBL] [Abstract][Full Text] [Related]
5. Breast Relapse of Pediatric B-Cell Acute Lymphoblastic Leukemia After CAR-T Therapy Detected by
Perrone E; Taralli S; Pagliara D; Larocca LM; Vinti L; Leccisotti L
Anticancer Res; 2024 May; 44(5):2243-2245. PubMed ID: 38677722
[TBL] [Abstract][Full Text] [Related]
6. Gamma delta lymphoma: a pictorial review of F-18 fluorodeoxyglucose PET/CT findings and a brief review of the literature.
Rayamajhi SJ; Ponisio MR; Mehta-Shah N
Br J Radiol; 2024 Jan; 97(1153):41-52. PubMed ID: 38263839
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of CT‑based radiomics model of PET-negative residual CT masses: a potential biomarker for predicting relapse‑free survival in non-Hodgkin lymphoma patients showing complete metabolic response.
Cha SH; Kang KW; Han NY; Cho Y; Sung DJ; Park BJ; Kim MJ; Sim KC; Han YE; Sung HJ
Abdom Radiol (NY); 2024 Jan; 49(1):341-353. PubMed ID: 37884749
[TBL] [Abstract][Full Text] [Related]
8. FDG-PET/CT is a powerful tool to predict and evaluate response to chimeric antigen receptor (CAR) T-cell therapy in Non-Hodgkin-Lymphoma (NHL).
Wielenberg CF; Fostitsch JC; Volz C; Marks R; Michalski K; Wäsch R; Zeiser R; Ruf J; Meyer PT; Klein C
Nuklearmedizin; 2024 Apr; ():. PubMed ID: 38593856
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET/CT response assessment with qualitative Lugano criteria outperforms change in SUV
Russler-Germain DA; Calhoun BR; Wu N; Watkins MP; Siegel BA; Bartlett NL; Mhlanga JC
Leuk Lymphoma; 2023; 64(11):1870-1874. PubMed ID: 37489928
[No Abstract] [Full Text] [Related]
10. Early Evaluation of Immunotherapy Response in Lymphoma Patients by 18F-FDG PET/CT: A Literature Overview.
Ferrari C; Maggialetti N; Masi T; Nappi AG; Santo G; Niccoli Asabella A; Rubini G
J Pers Med; 2021 Mar; 11(3):. PubMed ID: 33803667
[TBL] [Abstract][Full Text] [Related]
11. Recent advancements in
Jamalipour Soufi G; Hekmatnia A; Hekmatnia F; Zarei AP; Shafieyoon S; Azizollahi S; Ghazanfari Hashemi M; Riahi F
Am J Nucl Med Mol Imaging; 2024; 14(2):97-109. PubMed ID: 38737646
[TBL] [Abstract][Full Text] [Related]
12. Biopsy site identified with FDG PET-CT for diagnosis of tuberculosis in a child.
Goussard P; Burger C; Rabie H; Andronikou S
BMJ Case Rep; 2022 Jan; 15(1):. PubMed ID: 35039377
[No Abstract] [Full Text] [Related]
13. Editorial Comment: FDG PET/CT Has Impact in Chimeric Antigen Receptor T-Cell Therapy Response Assessment and Outcome Prediction.
Marcus C
AJR Am J Roentgenol; 2024 Mar; 222(3):e2330703. PubMed ID: 38117102
[No Abstract] [Full Text] [Related]
14. Bilateral cytomegalovirus infection of the adrenal glands revealed by
Van Bogaert C; Vierasu I; Mathey C; Theunissen A; Goldman S
Clin Case Rep; 2022 Jan; 10(1):e05005. PubMed ID: 35127088
[TBL] [Abstract][Full Text] [Related]
15. Sociodemographic factors and Child Opportunity Index disparities associated with missed care opportunities in pediatric patients with lymphoma and leukemia referred for FDG-PET/CT.
Harrington S; Kwatra N; Melvin P; Tartarilla AB; Whitley MY; Valencia VF; Ward VL
Pediatr Radiol; 2024 May; 54(6):1022-1032. PubMed ID: 38632134
[TBL] [Abstract][Full Text] [Related]
16. Different roles of surveillance positron emission tomography according to the histologic subtype of non-Hodgkin's lymphoma.
Kim YR; Kim SJ; Cheong JW; Kim Y; Jang JE; Cho H; Chung H; Min YH; Yang WI; Cho A; Kim JS
Korean J Intern Med; 2021 Mar; 36(Suppl 1):S245-S252. PubMed ID: 32550718
[TBL] [Abstract][Full Text] [Related]
17. Utility of
Jitani AK; Dutta S; Mandal PK; De R; Jajodia E; Baul S; Chakrabarti P; Dolai TK
Indian J Med Res; 2021 May; 154(5):691-698. PubMed ID: 35532587
[TBL] [Abstract][Full Text] [Related]
18. Frequent impact of [18F]fluorodeoxyglucose positron emission tomography on the staging and management of patients with indolent non-Hodgkin's lymphoma.
Blum RH; Seymour JF; Wirth A; MacManus M; Hicks RJ
Clin Lymphoma; 2003 Jun; 4(1):43-9. PubMed ID: 12837154
[TBL] [Abstract][Full Text] [Related]
19. Value of
Alobthani G; Romanov V; Isohashi K; Matsunaga K; Watabe T; Kato H; Tatsumi M; Shimosegawa E; Hatazawa J
Hell J Nucl Med; 2018; 21(1):7-14. PubMed ID: 29550841
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
